Individuals Coming Off Anti-Obesity Injections Put On Pounds Four Times Faster Compared to People Using Diet and Exercise

Illustration of medical injection and scale
Obesity treatment involves ongoing approaches.

A recent study indicates that individuals who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise plans.

Published data in a major medical journal demonstrates that while overweight individuals can lose substantial amounts of their body weight while on the medication, the weight returns at an estimated rate of 0.8 kg per month after stopping.

"Users buying these treatments should be aware of the danger of quick weight regain when the medication ends," warns researcher Dr. Susan Jebb.

That rate of recovery implies a reversion to original weight in about one and a half years.

Comparing Treatments

The analysis, which reviewed 37 of studies involving thousands of participants, contrasted the results of these new drugs with other pills.

Scientists note that people who lose weight through dieting usually see a less rapid weight regain—perhaps 100 grams monthly—once they finish.

Understanding the Fast Regain

Experts propose the mechanism of the injections is key to understanding the heightened rebound.

These medications imitate a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Long-term administration of GLP-1 concentrations far above than the body's typical production may cause the system to produce less of its own natural GLP-1, and could lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making overeating a significant risk."

A Lifelong Disease?

The NHS recommend the injections for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.

Many experts contend that, considering the significant potential of relapse, the treatment is often ongoing.

This opinion is reinforced by pharmaceutical companies, who state that the results "emphasize the chronic character of obesity," comparing it to managing conditions like hypertension.

User Experiences

People who have discontinued the jabs report a sudden return of appetite.

"It felt as if a trigger flipping and you become starving," said an individual.

This challenge is worsened if patients have not established lasting lifestyle or habit modifications during treatment.

Significant Interest

Survey data show that millions of people in the UK have used these injections in the past year, with demand continuing to grow.

  • Use is greater among females compared to males.
  • The 40s and 50s age group shows the greatest usage rates.
  • Many access the medications through private prescriptions rather than the NHS.

Finally, researchers emphasize that while the jabs are effective agents for weight loss, they are not a magic cure and maintained weight loss hinges on integrated lifestyle changes.

Tammy Vargas
Tammy Vargas

A seasoned sports analyst with over a decade of experience in betting strategies and casino gaming, specializing in Canadian markets.